Strontium-82 (t1/2 = 25.5 d) is one of the medical isotopes produced on a large scale at the Isotope Production Facility (IPF) of the Los Alamos National Laboratory (LANL), employing a high intensity 100 MeV proton beam and RbCl targets. A constant increase in the 82Sr demand over the last decade combined with an established thermal limit of molten RbCl salt targets [1,2] has challenged the IPF’s world leading production capacity in recent years and necessitated the consideration of low-melting point (39.3 °C) Rb metal targets. Metal targets are used at other facilities [3–5] and offer obvious production rate advantages due to a higher relative density of Rb target atoms and a higher expected thermal performance of molten metal. One major d...
International audienceThe ARRONAX cyclotron is fully operational since the end of 2010. It delivers ...
With recent impressive clinical results of targeted alpha therapy using 225Ac, significant effort ha...
The brightness of the antiproton source increases as the proton beam spot size on the target is redu...
Strontium-82 (t1/2 = 25.5 d) is one of the medical isotopes produced on a large scale at the Isotope...
Introduction Sr-82 is produced for PET cardiac imaging at the Isotope Production Facility (IPF) with...
Introduction The Los Alamos Isotope Production Program commonly irradiates target stacks consisting...
Introduction Low melting point metals are often encapsulated in a hermetic container, irradiated an...
A fully automated system was developed to produce rubidium-81 (81Rb), based on the natKr (p, n) 81Rb...
The production of 82Sr at iThemba LABS is performed by the proton bombardment of a RbCl target using...
Targets employing refractory compounds are being developed for the rare isotope accelerator (RIA) fa...
The Isotope Production Facility (IPF) at Los Alamos is operated on the authorization basis of a radi...
With the aim of increasing the primary beam intensity in the next generation Radioactive Ion Beam fa...
Megawatt-class molten targets, combining high material densities and good heat transfer properties a...
85Sr was produced via the 85Rb(p,n)85Sr reaction. Rubidium chloride deposition on copper substrate w...
International audienceThe ARRONAX cyclotron is fully operational since the end of 2010. It delivers ...
With recent impressive clinical results of targeted alpha therapy using 225Ac, significant effort ha...
The brightness of the antiproton source increases as the proton beam spot size on the target is redu...
Strontium-82 (t1/2 = 25.5 d) is one of the medical isotopes produced on a large scale at the Isotope...
Introduction Sr-82 is produced for PET cardiac imaging at the Isotope Production Facility (IPF) with...
Introduction The Los Alamos Isotope Production Program commonly irradiates target stacks consisting...
Introduction Low melting point metals are often encapsulated in a hermetic container, irradiated an...
A fully automated system was developed to produce rubidium-81 (81Rb), based on the natKr (p, n) 81Rb...
The production of 82Sr at iThemba LABS is performed by the proton bombardment of a RbCl target using...
Targets employing refractory compounds are being developed for the rare isotope accelerator (RIA) fa...
The Isotope Production Facility (IPF) at Los Alamos is operated on the authorization basis of a radi...
With the aim of increasing the primary beam intensity in the next generation Radioactive Ion Beam fa...
Megawatt-class molten targets, combining high material densities and good heat transfer properties a...
85Sr was produced via the 85Rb(p,n)85Sr reaction. Rubidium chloride deposition on copper substrate w...
International audienceThe ARRONAX cyclotron is fully operational since the end of 2010. It delivers ...
With recent impressive clinical results of targeted alpha therapy using 225Ac, significant effort ha...
The brightness of the antiproton source increases as the proton beam spot size on the target is redu...